GLP-1 Bridge
Coverage of GLP-1 Bridge in the Nexus archive.
- The Upside-Down World of the GLP-1 Bridge
A healthcare professional examines electronic medical records to investigate the GLP-1 Bridge, focusing on patient data without immediate life-threatening concerns.
- Dr. Oz’s GLP-1 Bridge could work, but it isn’t a model for price controls
Dr. Oz’s GLP-1 Bridge may be effective but is not a viable model for price controls. The article warns that consumer discounts today could hinder future medical advancements.
- STAT+: Medicare still won’t say how much covering obesity drugs will cost
Medicare will cover Wegovy and Zepbound for weight loss starting July 2024 at $50/month for beneficiaries, but has not disclosed the cost to taxpayers. The temporary 'GLP-1 Bridge' program, running until December 2027, bypasses federal law and shifts most costs to taxpayers. The Trump administration initially planned coverage through Medicare Advantage plans, but insurers opposed due to high costs.